Kluess HA, Jones RL, Lee-Fowler T
BMI Requirements for GLP-1 Weight Loss Treatment Eligibility Body Mass Index serves as the primary screening metric for GLP-1 eligibility
It is important for patients to consult with their doctor regarding other GLP-1 RA options such as Victoza (liraglutide), Trulicity (dulaglutide), Byetta or Bydureon BCise (exenatide), Rybelsus (oral semaglutide), Mounjaro (tirzepatide), Adlyxin (lixisenatide), etc
Use liquid nutrition as a bridge, not a skip
HMSC pretreated with Ex-4 or modified to express Exendin-4 (hMSC-Ex-4) showed reduced HO-induced apoptosis and increased phosphorylated AMPK levels, effects blocked by the AMPK inhibitor compound C [18]
This stands in contrast to the hepatotoxicity that terminated Pfizer's danuglipron and lotiglipron programs